Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Botulinum Vaccine A/B

· DynPort Vaccine Company LLC (A GDIT Company)
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Recombinant Botulinum Vaccine A/B, covering 2011-12-02 to 2018-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B [Phase 3]

See pricing